RNS Number:5658L
ReGen Therapeutics PLC
27 May 2003


ReGen Therapeutics Plc

27 May 2003


SUBSTANTIAL SHAREHOLDING

ReGen Therapeutics Plc (the "Company") announces that on 27 May 2003 it received
notification from Mr P Garrod that he is beneficially interested in 12,800,000
ordinary shares of the Company representing 7.95% of the current issued share
capital of the Company.



For further information, please contact:

Andrew Marshall
Marshall Robinson Roe
Tel. 020 7489 2033



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLEALSXASXDEFE